866-997-4948 (US-Canada Toll Free)

Liver Cancer Market

  • Metastatic Liver Cancer-Pipeline Insights, 2015

    Apr 2015

    By DelveInsight

    Pharmaceutical

    0 Pages

    SUMMARY DelveInsights, Metastatic Liver Cancer-Pipeline Insights, 2015, report provides comprehensive insights about pipeline drugs across this Metastatic Liver Cancer. A key objective of DelveInsights report is to establish the understanding for all the pipeline drugs that fall under Metastatic Liver Cancer. The report provides information on the therapeutic development based on the...

    USD 1250View Report
  • Metastatic Liver Cancer - Pipeline Review, H1 2015

    Mar 2015

    By Global Markets Direct

    Pharmaceutical

    67 Pages

    Global Markets Directs, Metastatic Liver Cancer Pipeline Review, H1 2015, provides an overview of the Metastatic Liver Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route...

    USD 2000View Report
  • Liver Cancer Partnering 2010-2015

    Mar 2015

    By Current Partnering

    Oncology

    150 Pages

    The Liver Cancer Partnering 2010-2015 report provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in liver cancer partnering deals Top Liver cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Liver...

  • Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

    Jan 2015

    By GBI Research

    Pharmaceutical

    0 Pages

    Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. The contrast...

    USD 6995View Report
  • Metastatic Liver Cancer-Pipeline Insights, 2014

    Aug 2014

    By DelveInsight

    Pharmaceutical

    0 Pages

    The Report will be Dispatched in 3 Working Days.  DelveInsights, Metastatic Liver Cancer-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Metastatic Liver Cancer. This report provides information on...

    USD 1250View Report
  • Metastatic Liver Cancer - Pipeline Review, H2 2014

    Jul 2014

    By Global Markets Direct

    Pharmaceutical

    89 Pages

    Metastatic Liver Cancer - Pipeline Review, H2 2014 Summary Global Markets Directs, Metastatic Liver Cancer - Pipeline Review, H2 2014, provides an overview of the Metastatic Liver Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment...

    USD 2000View Report
  • Liver Cancer Treatment Drugs Markets in China

    Jun 2014

    By Asia Market Information & Development Company

    Therapeutic Area

    212 Pages

    China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003,...

    USD 4000View Report
  • Metastatic Liver Cancer - Pipeline Review, H1 2014

    Feb 2014

    By Global Markets Direct

    Oncology

    76 Pages

    Metastatic Liver Cancer - Pipeline Review, H1 2014 Summary Global Markets Directs, Metastatic Liver Cancer - Pipeline Review, H1 2014, provides an overview of the Metastatic Liver Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Liver Cancer, complete with comparative analysis at various stages, therapeutics assessment...

    USD 2000View Report
  • Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013

    Dec 2013

    By GlobalData

    Oncology

    99 Pages

    Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, Metastatic Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial...

    USD 2500View Report
  • Liver Cancer Global Clinical Trials Review, H2, 2013

    Nov 2013

    By GlobalData

    Oncology

    175 Pages

    GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook...

    USD 2500View Report
  • Liver Cancer - Pipeline Review, H2 2013

    Jul 2013

    By Global Markets Direct

    Healthcare

    616 Pages

    Global Markets Directs, Liver Cancer - Pipeline Review, H2 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Cancer....

    USD 2000View Report
  • Metastatic Liver Cancer - Pipeline Review, H2 2013

    Jul 2013

    By Global Markets Direct

    Healthcare

    53 Pages

    Global Markets Directs, Metastatic Liver Cancer Pipeline Review, H2 2013, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development...

    USD 2000View Report
  • Liver Cancer Partnering 2007-2013

    Jul 2013

    By Current Partnering

    Pharmaceutical

    150 Pages

    The Liver Cancer Partnering 2007-2013 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the...

  • Liver Cancer - Pipeline Review, H1 2013

    Feb 2013

    By Global Markets Direct

    Oncology

    596 Pages

    Global Markets Directs, 'Liver Cancer - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver...

    USD 2000View Report
  • Metastatic Liver Cancer - Pipeline Review, H1 2013

    Feb 2013

    By Global Markets Direct

    Oncology

    60 Pages

    Global Markets Directs, 'Metastatic Liver Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development...

    USD 2000View Report
  • Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail

    Dec 2012

    By GBI Research

    Oncology

    72 Pages

    Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail Summary Leading business intelligence provider, GBI Research, has released its latest research report, entitled: “Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted...

    USD 3500View Report
  • Liver Cancer Global Clinical Trials Review, H2, 2012

    Dec 2012

    By GlobalData

    Pharmaceutical

    159 Pages

    Liver Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2012" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their...

    USD 2500View Report
  • Liver Cancer - Pipeline Review, H2 2012

    Sep 2012

    By Global Markets Direct

    Pharmaceutical

    120 Pages

    Liver Cancer Pipeline Review, H2 2012 Global Markets Directs, 'Liver Cancer Pipeline Review, Global Markets Directs, 'Liver Cancer Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with latest updates, and special features on late-stage and...

    USD 2500View Report
  • Chinese Markets for Liver Cancer Treatment Drugs

    Aug 2012

    By Asia Market Information & Development Company

    Industry Profile

    210 Pages

    China's demand for liver cancer treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data...

    USD 4000View Report
  • Liver Cancer Partnering 2007-2012

    Jun 2012

    By Current Partnering

    Pharmaceutical

    150 Pages

    The Liver Cancer Partnering 2007-2012 provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the...

  • Liver Cancer Partnering Partnering 2007-2012

    Mar 2012

    By Current Partnering

    Pharmaceutical

    150 Pages

    This is an on demand report, it will take 20 to 25 working days to complete The ‘Liver Cancer Partnering 2007-2012’ provides understanding and access to the liver cancer partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of liver cancer partnering deals. The majority of deals are...

  • Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012

    Jan 2012

    By GlobalData

    Pharmaceutical

    96 Pages

      GlobalData's clinical trial report, Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial...

    USD 1000View Report
  • Liver Cancer Global Clinical Trials Review, H2, 2011

    Nov 2011

    By GlobalData

    Pharmaceutical

    139 Pages

    Liver Cancer Global Clinical Trials Review, H2, 2011 GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2011" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as...

    USD 1000View Report
  • Liver Cancer Global Clinical Trials Review, Q4, 2010

    Dec 2010

    By GlobalData

    Oncology

    75 Pages

    GlobalData's clinical trial report, “ Liver Cancer Global Clinical Trials Review, Q4, 2010"" provides data on the Liver Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world,...

    USD 1000View Report
  • Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010

    Dec 2010

    By GlobalData

    Oncology

    66 Pages

    GlobalData's clinical trial report, Metastatic Liver Cancer Global Clinical Trials Review, Q4, 2010" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Metastatic Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial...

    USD 1000View Report